W.G. Shaheen & Associates DBA Whitney & Co Buys 285 Shares of Cigna Group $CI

W.G. Shaheen & Associates DBA Whitney & Co increased its stake in Cigna Group (NYSE:CIFree Report) by 0.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 52,319 shares of the health services provider’s stock after buying an additional 285 shares during the period. Cigna Group accounts for 1.7% of W.G. Shaheen & Associates DBA Whitney & Co’s portfolio, making the stock its 20th largest position. W.G. Shaheen & Associates DBA Whitney & Co’s holdings in Cigna Group were worth $17,296,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of CI. Flaharty Asset Management LLC bought a new position in Cigna Group in the first quarter worth about $28,000. 1248 Management LLC bought a new position in Cigna Group in the first quarter worth about $29,000. Solstein Capital LLC bought a new position in shares of Cigna Group during the second quarter valued at approximately $29,000. Activest Wealth Management increased its stake in shares of Cigna Group by 360.0% during the first quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock valued at $30,000 after purchasing an additional 72 shares in the last quarter. Finally, Chilton Capital Management LLC bought a new position in shares of Cigna Group during the second quarter valued at approximately $30,000. 86.99% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have weighed in on CI shares. Guggenheim decreased their target price on shares of Cigna Group from $350.00 to $309.00 in a research note on Friday. Morgan Stanley reaffirmed an “overweight” rating and set a $355.00 target price on shares of Cigna Group in a research note on Friday. Cantor Fitzgerald decreased their target price on shares of Cigna Group from $365.00 to $325.00 in a research note on Friday. Barclays set a $300.00 target price on shares of Cigna Group in a research note on Friday. Finally, Wolfe Research reduced their price target on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, October 15th. Two analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $350.74.

View Our Latest Report on CI

Insider Activity at Cigna Group

In related news, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the sale, the insider owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of the firm’s stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the sale, the insider owned 51,182 shares in the company, valued at $15,354,600. This represents a 9.49% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 0.70% of the company’s stock.

Cigna Group Price Performance

Shares of CI opened at $244.67 on Monday. The company has a market capitalization of $65.31 billion, a P/E ratio of 13.36, a price-to-earnings-growth ratio of 0.88 and a beta of 0.45. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. The firm has a 50 day moving average of $297.19 and a 200 day moving average of $305.80. Cigna Group has a twelve month low of $240.67 and a twelve month high of $350.00.

Cigna Group (NYSE:CIGet Free Report) last issued its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.64 by $0.19. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. During the same quarter last year, the company posted $7.51 earnings per share. The firm’s quarterly revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities research analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be issued a $1.51 dividend. The ex-dividend date is Thursday, December 4th. This represents a $6.04 annualized dividend and a yield of 2.5%. Cigna Group’s dividend payout ratio (DPR) is currently 26.64%.

Cigna Group Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Further Reading

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.